Promoting Male Involvement to Improve PMTCT Uptake and Reduce Antenatal HIV Infection [retrospectively registered]

• Register: PACTR
• Last refreshed on: 29 April 2013
• Main ID: PACTR201109000318329
• Date of registration: 24/09/2011
• Primary sponsor: Human Sciences Research Council
• Public title: Promoting Male Involvement to Improve PMTCT Uptake and Reduce Antenatal HIV Infection [retrospectively registered]
• Scientific title: Promoting Male Involvement to Improve PMTCT Uptake and Reduce Antenatal HIV Infection
• Date of first enrolment: 2010-12-13
• Target sample size: 478
• Recruitment status: Completed: recruitment & data analysis complete
• URL: HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201109000318329
• Study type: interventional
• Study design: Factorial: participants randomly allocated to either no,one,some or all interventions simultaneously,; Randomised,; Permuted block randomisation: block size=12 community health centers matched by patient volume,; Allocation was determined by the holder of the sequence who is situated off site,

Countries of recruitment

South Africa

Contacts

• Name: Karl Peltzer
• Affiliation: Research Director/HSRC

• Name: Karl Peltzer
• Affiliation: Research Director/HSRC

Key inclusion & exclusion criteria

Inclusion criteria: Inclusion criteria: Eligible participants will be male and female. Women: a) pregnant women age 18 and older who have received HCT at the ANC, b) willing to attend PartnerPlus or PMTCT visits with their male partners, c) male partners must also be available to participate and d) both partners must be willing to participate in the study. Men: a) men aged 18 and older who are partners of pregnant women enrolled in the study, b) willing to attend PartnerPlus or PMTCT visits with their female partners, c) female partners must also be enrolled in the study and available to participate. All participants will be current adult residents of Mpumalanga Province and agree to attend four group sessions, 2 psychosocial assessments and 1 three day post-delivery assessment (maternal and infant only - blood sample assessment).
Exclusion criteria: Exclusion Criteria: Women who are not currently pregnant or are unwilling to receive HCT are not eligible for this study. Women whose partners are not willing to participate are not eligible for this study. Men whose pregnant partners are unwilling to participate are not eligible for this study. Women and men who are not couples are not eligible to participate. Participants unable to provide informed consent will not be eligible.

Age minimum: 18 Year
Age maximum: 60 Year
Gender: Both

Health Condition(s) or Problem(s) studied

HIV/AIDS
null

Primary Outcome(s)

1) increasing male partner participation in the PMTCT process, 2) increasing male HCT, 3) increasing maternal and infant adherence to the overall PMTCT protocol,

Secondary Outcome(s)

increasing the use of sexual barriers and reducing HIV transmission to mothers during pregnancy.

Source(s) of Monetary Support

NIH